Morgan Stanley Sticks to Their Buy Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)
at www.tipranks.com (Wed, 3-Dec 12:05 AM)
Resmed’s Strategic Positioning and Market Valuation Suggest 19% Upside Despite Future CMS Challenges
at www.tipranks.com (Mon, 1-Dec 6:25 AM)
